The National Biosafety Authority has approved field trials for testing Genetically Modified vaccines for the control of Rift Valley Fever (RVF) disease in cattle, goats, sheep and camels.
RVF is a zoonotic viral disease primarily affecting animals and is transmitted by mosquitoes and other insects and is endemic in Africa and the Middle East.
Speaking on the sidelines of the 13th Annual Biosafety Conference, Dr.
Martin Mwirigi, the Institute Director of the Biotechnology Research Institute at the Kenya Agricultural and Livestock Research Organization, said they were coming out from the conventional way of developing vaccines and now using biotechnology.
